Skip to main content

Influence of Inhibitors on the Thrombogenicity and Toxicity of Prothrombin Complex Concentrates

  • Conference paper
Mechanisms and Models in Toxicology

Part of the book series: Archives of Toxicology, Supplement ((TOXICOLOGY,volume 11))

  • 177 Accesses

Abstract

Patients treated with prothrombin complex concentrates (PCCs) have frequently been found to develop arterial thrombosis, venous thromboembolism or disseminated intravascular coagulation (Kasper 1975). Consequently, PCCs must be regarded as potentially thrombogenic substances (Elodi 1977). Within the framework of studies of a new PCC (Klöcking et al. 1984), the influence of heparin, pentosan polysulphate and synthetic thrombin inhibitors on the thrombogenicity of PCCs was examined. Furthermore, the effect of heparin, pentosan polysulphate or aprotinin was studied on the acute toxicity of PCC and on that observed after 7 days.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Elodi S (1977) Thrombogenic properties of prothrombin complex concentrates. Blood 50:961–965

    PubMed  Google Scholar 

  • Kasper CK (1975) Thromboembolic complications. Thrombos Diathes Haemorrh 33:640–644

    CAS  Google Scholar 

  • Klöcking H-P, Kleßien Ch, Jablonowski Ch, Meerbach W, Dornheim G (1984) Untersuchungen zur Thrombogenität eines neuen Prothrombinkomplexkonzentrates. Folia Haematol 111:645–661

    Google Scholar 

  • Litchfield JT, Wilcoxon P (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113

    PubMed  CAS  Google Scholar 

  • Magner A, Aronson DL (1979) Toxicity in mice of factor IX concentrates. Thrombos Haemostas 42:200

    Google Scholar 

  • Menarche D (1975) Factor IX concentrates. Thrombos Diathes Haemorrh 33:600–605

    Google Scholar 

  • Wessler S (1955) Studies in intravascular coagulation. The pathogenesis of serum-induced venous thrombosis. J Clin Invest 34:647–653

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag

About this paper

Cite this paper

Klöcking, HP., Dornheim, G., Schulze-Riewald, H. (1987). Influence of Inhibitors on the Thrombogenicity and Toxicity of Prothrombin Complex Concentrates. In: Chambers, C.M., Chambers, P.L., Davies, D.S. (eds) Mechanisms and Models in Toxicology. Archives of Toxicology, Supplement, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72558-6_60

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72558-6_60

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-17614-5

  • Online ISBN: 978-3-642-72558-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics